The International Council for Harmonisation (ICH) has recently announced the development of the new Quality guidelines (Q13 and Q14) relating to continuous manufacturing and analytical procedure development respectively.  In addition to guiding the industry and regulatory agencies on the requirements of continuous manufacturing technologies used in the manufacture of pharmaceuticals, these also reflect the key intent to harmonise the scientific approaches of analytical procedure development, through understanding the underlying principles. This seminar provides a valuable opportunity to hear from Dr Moheb who is highly involved in developing these guidelines, as he draws also from his immense experience to share on the impact of the trending movement in the regulation of pharmaceuticals.

Prof John Lim
Executive Director, CoRE
Duke- NUS Medical School
Core Lead (Policy)
Singhealth Duke-NUS Global Health Institute

Registration Fee: $70

Click here to register.

Sherna Wadia (sherna.wadia@duke-nus.edu.sg)